Printer Friendly

MARION MERRELL DOW ACQUIRES GERMAN PHARMACEUTICAL COMPANY

 MARION MERRELL DOW ACQUIRES GERMAN PHARMACEUTICAL COMPANY
 KANSAS CITY, Mo, Nov. 26 /PRNewswire/ -- Marion Merrell Dow Inc. (NYSE: MKC) today announced it has taken steps to strengthen its presence in the international marketplace with the signing of an agreement to acquire Henning Berlin GmbH, a closely held German pharmaceutical company headquartered in Berlin. The financial terms of the acquisition, which is subject to German regulatory approval, were not disclosed.
 Henning Berlin GmbH is involved in the development, manufacture, marketing and sale of a line of products for the treatment of thyroid disorders and associated diagnostic tests. The company's other product lines include therapies for the treatment of osteoporosis, cardiovascular disorders, and inflammatory bowel diseases.
 Henning Berlin GmbH will continue to operate under its current name and will remain based in Berlin. With projected 1991 sales of approximately $70 million, Henning Berlin GmbH employs approximately 450 associates, including a field sales force of about 100.
 Merrell Dow Pharma GmbH, the Marion Merrell Dow subsidiary that manages the company's German business activities, has approximately 200 associates, of which some 135 are field sales personnel. Merrell Dow Pharma GmbH's sales during 1991 are projected at $55 million.
 "The purchase of Henning Berlin GmbH fits well with our corporate strategy of expanding our business in selected geographic areas around the world," said Marion Merrell Dow President Fred W. Lyons, Jr. "This acquisition extends our base of operations in an expanded Germany, where we already have a recognized presence and where we see excellent growth potential. It also gives us the opportunity to expand the markets for Henning Berlin's product lines outside of Germany."
 Headquartered in Kansas City, Marion Merrell Dow is involved in the discovery, development, manufacture and marketing of prescription and over-the-counter pharmaceutical products in North America, Europe and the Pacific Basin. The company employs some 9,000 associates and in 1990 generated total sales of $2.5 billion.
 -0- 11/26/91
 /CONTACT: Larry W. Wheeler or David M. Thompson both of Marion Merrell Dow, 816-966-4000/
 (MKC) CO: Marion Merrell Dow Inc. ST: Missouri IN: MTC SU:


MC -- DV010 -- 7571 11/26/91 18:47 EST
COPYRIGHT 1991 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1991 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 26, 1991
Words:354
Previous Article:DAVENPORT BANK STOCKHOLDERS APPROVE ACQUISITION BY NORWEST
Next Article:ANNUAL CHRISTMAS PRICE INDEX RUNNING OVER ASSOCIATED PRESS WIRE; FLORIDA ANGLE AVAILABLE
Topics:


Related Articles
MARION MERRELL DOW COMPLETES ACQUISITION OF HENNING BERLIN GMBH
MARION MERRELL DOW ACQUIRES GENERIC DRUG BUSINESS OF RUGBY-DARBY GROUP COMPANIES
MARION MERRELL DOW COMPLETES ACQUISITION OF AMERICA'S LARGEST GENERIC DRUG COMPANY
MARION MERRELL DOW INC. INCREASES ITS OWNERSHIP IN JAPAN'S KODAMA LTD.
MARION MERRELL DOW INC. TO ACQUIRE SELECTIDE CORP. FOR ENABLING TECHNOLOGIES IN R&D
MARION MERRELL DOW INC. COMPLETES ACQUISITION OF SELECTIDE CORP. TO ACCELERATE DRUG DISCOVERY
HOECHST, MARION MERRELL DOW AND DOW CHEMICAL MAKE JOINT ANNOUNCEMENT
HOECHST AGREES TO ACQUIRE MARION MERRELL DOW
COMPANIES ANNOUNCE DEFINITIVE AGREEMENTS FOR HOECHST TO ACQUIRE MARION MERRELL DOW
HOECHST AG COMPLETES ACQUISITION OF MARION MERRELL DOW INC. - A STEP TOWARD GLOBAL LEADERSHIP IN PHARMACEUTICALS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters